MedTrace Logo

CCTG 594: Engagement and Retention in Care for HIV+

NCT01957748 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 117

Last updated 2021-12-09

No results posted yet for this study

Summary

CCTG 594 is a controlled, unblinded, two-arm, randomized (1:1) clinical trial to evaluate the effectiveness of a clinic-based HIV ALERT specialist on improving endpoints of retention in care and maintenance of ART as compared to the current standard of care (SoC) in HIV primary care clinics.

Conditions

  • Patient Adherence
  • HIV Positive

Interventions

BEHAVIORAL

SoC + ALERT Intervention

Enhanced retention efforts and education modules will be implemented by the ALERT Specialist to ensure retention to care.

Sponsors & Collaborators

Principal Investigators

  • Maile Karris, MD · CCTG, UCSD AVRC, UCSD Owen Clinic

  • Katya Calvo, MD · CCTG, Harbor-UCLA

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-08
Primary Completion
2017-12-15
Completion
2020-11-24

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01957748 on ClinicalTrials.gov